Key result
Current clinical practices result in 10-40% of patients experiencing postoperative residual weakness, highlighting the need for improved neuromuscular blockade monitoring and basic guidelines.
Unrecognised postoperative residual neuromuscular block remains frequent, highlighting the need for improved monitoring practices and guidelines.
Answers are grounded in this paper and cite their sources.
Alerts clinicians to ongoing risks of residual paralysis; leaves open optimal monitoring protocols and guideline implementation strategies.
Unrecognised postoperative residual neuromuscular block remains a frequent occurrence in recovery rooms. Evidence indicates that current practice continues to perpetuate the status quo, in which 10-40% of patients experience postoperative residual weakness. A departure from the current practice requires small efforts on the clinicians' part. This review addresses several selected core questions regarding neuromuscular blockade monitoring and provides a framework to rationally discuss and develop basic guidelines for the use of neuromuscular blocking agents in patient care.
No takes yet. Share an insight, caveat, or question.
Naguib et al. (2017) conducted a review in Postoperative residual neuromuscular block. Neuromuscular blockade monitoring was evaluated. Current clinical practices result in 10-40% of patients experiencing postoperative residual weakness, highlighting the need for improved neuromuscular blockade monitoring and basic guidelines.
Synapse has enriched 10 related papers. Consider them for comparative context: